Cargando…

Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness

Background: Glioblastoma (GB) is one of the most common (~30%) and lethal cancers of the central nervous system. Although new therapies are emerging, chemoresistance to treatment is one of the major challenges in cancer treatment. Brain cytoplasmic 200 (BC200) RNA, also known as BCYRN1, is a long no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Yu-Kai, Lin, Jia Wei, Shih, Jing-Wen, Chuang, Hao-Yu, Fong, Iat-Hang, Yeh, Chi-Tai, Lin, Chien-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463574/ https://www.ncbi.nlm.nih.gov/pubmed/32784466 http://dx.doi.org/10.3390/cells9081859

Ejemplares similares

Ubiquitin-Specific Protease 6 n-Terminal-like Protein (USP6NL) and the Epidermal Growth Factor Receptor (EGFR) Signaling Axis Regulates Ubiquitin-Mediated DNA Repair and Temozolomide-Resistance in Glioblastoma
por: Su, I-Chang, et al.
Publicado: (2022)

The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2–HO-1 Axis
por: Chuang, Hao-Yu, et al.
Publicado: (2021)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021)

Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTK/mTOR/VEGF Signaling
por: Su, Yu-Kai, et al.
Publicado: (2021)

Cinnamophilin enhances temozolomide-induced cytotoxicity against malignant glioma: the roles of ROS and cell cycle arrest
por: Tai, Shih-Hang, et al.
Publicado: (2021)

Inhibition of Mitochondria- and Endoplasmic Reticulum Stress-Mediated Autophagy Augments Temozolomide-Induced Apoptosis in Glioma Cells
por: Lin, Chien-Ju, et al.
Publicado: (2012)

Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma
por: Liu, Heng-Wei, et al.
Publicado: (2019)

Identification of pBC218/pBC210 Genes of Bacillus cereus G9241 in Five Florida Soils Using qPCR
por: Luna, Vicki Ann, et al.
Publicado: (2014)

Slit-miR-218-Robo axis regulates retinal neovascularization
por: Kong, Yichun, et al.
Publicado: (2016)

Job scheduling strategies for parallel processing: 22nd international workshop, JSSPP 218, Vancouver, BC, Canada, May 25, 218, revised selected papers
por: Klusáček, Dalibor, et al.
Publicado: (2019)

Correction: Liu, H.W.; et al. Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma. Cancers 2019, 11, 1888
por: Liu, Heng-Wei, et al.
Publicado: (2020)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages
por: Chuang, Hao-Yu, et al.
Publicado: (2019)

Differential Characterization of Temozolomide-Resistant Human Glioma Cells
por: Lai, Sheng-Wei, et al.
Publicado: (2018)

Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells
por: Tiong, Tung-Yu, et al.
Publicado: (2022)

Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory α7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm
por: Lin, Yen-Kuang, et al.
Publicado: (2022)

Sevoflurane Limits Glioma Progression by Regulating Cell Proliferation, Apoptosis, Migration, and Invasion via miR-218-5p/DEK/β-Catenin Axis in Glioma
por: Qi, Yingying, et al.
Publicado: (2021)

SPDR-01 INHIBITION OF HOMOLOGOUS RECOMBINATION, PARP INHIBITOR, OR DIANHYDROGALACTITOL OVERCOMES TEMOZOLOMIDE-RESISTANCE IN GLIOMA CELLS
por: Ohba, Shigeo, et al.
Publicado: (2019)

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018)

Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis
por: Deng, Yanyao, et al.
Publicado: (2020)

Pterostilbene Increases LDL Metabolism in HL-1 Cardiomyocytes by Modulating the PCSK9/HNF1α/SREBP2/LDLR Signaling Cascade, Upregulating Epigenetic hsa-miR-335 and hsa-miR-6825, and LDL Receptor Expression
por: Lin, Yen-Kuang, et al.
Publicado: (2021)

Role of GDF15/MAPK14 Axis in Chondrocyte Senescence as a Novel Senomorphic Agent in Osteoarthritis
por: Weng, Pei-Wei, et al.
Publicado: (2022)

The Multifunction Of miR-218-5p-Cx43 Axis In Breast Cancer
por: Xia, Chen, et al.
Publicado: (2019)

NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation
por: Su, I-Chang, et al.
Publicado: (2023)

circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis
por: Ma, Xueyou, et al.
Publicado: (2021)

Novel NFκB Inhibitor SC75741 Mitigates Chondrocyte Degradation and Prevents Activated Fibroblast Transformation by Modulating miR-21/GDF-5/SOX5 Signaling
por: Weng, Pei-Wei, et al.
Publicado: (2021)

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis
por: Tang, Jun-Hai, et al.
Publicado: (2019)

The Multifunction of miR-218-5p-Cx43 Axis in Breast Cancer [Retraction]
Publicado: (2023)

β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)

Exosomal circWDR62 promotes temozolomide resistance and malignant progression through regulation of the miR-370-3p/MGMT axis in glioma
por: Geng, Xiuchao, et al.
Publicado: (2022)

BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide
por: CHEN, CHIEN-MIN, et al.
Publicado: (2015)

miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22
por: Li, Xiaodong, et al.
Publicado: (2017)

Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
por: Shi, Hui, et al.
Publicado: (2020)

SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance
por: Wang, Zhen, et al.
Publicado: (2017)

Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)
por: Kumari, Sonali, et al.
Publicado: (2017)

In search of effective therapies to overcome resistance to Temozolomide in brain tumours
por: Bouzinab, Kaouthar, et al.
Publicado: (2019)

Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
por: Wang, Chun, et al.
Publicado: (2023)

The Multifunction of miR-218-5p-Cx43 Axis in Breast Cancer [Expression of Concern]
Publicado: (2022)

BC200 RNA: An Emerging Therapeutic Target and Diagnostic Marker for Human Cancer
por: Shin, Heegwon, et al.
Publicado: (2018)

BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis
por: Barton, Maria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dhuj495vsm83em8soa3jtgfls8